MDT Insider Trading
Medtronic plc | Electromedical & Electrotherapeutic Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Medtronic plc provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Electromedical & Electrotherapeutic Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-22 00:13 | 2025-11-19 | Smith Gregory L | Officer - EVP Global Ops & Supply Chain | SELL | $101.95 | 30,000 | $3,058,452 | 46,016 | -39.5% |
| 2025-09-05 23:18 | 2025-09-03 | KIIL HARRY SKIP | Officer - EVP & President Cardiovascular | SELL | $91.58 | 8,605 | $788,048 | 35,615 | -19.5% |
| 2025-08-26 00:18 | 2025-08-22 | Jellison William R | Director | BUY | $92.55 | 5,000 | $462,750 | 5,000 | +100.0% |
| 2025-01-28 01:35 | 2025-01-24 | Wall Brett A. | Officer - EVP & Pres Neuroscience | OPT+S | $90.00 | 12,437 | $1,119,330 | 40,979 | 0.0% |
| 2025-01-11 00:48 | 2025-01-08 | Wall Brett A. | Officer - EVP & Pres Neuroscience | OPT+S | $80.41 | 9,850 | $792,039 | 40,708 | 0.0% |
| 2024-06-12 01:53 | 2024-06-07 | Martha Geoffrey | Director, Officer - Chairman and CEO | OPT+S | $83.77 | 19,113 | $1,601,000 | 143,348 | 0.0% |
| 2024-04-09 23:08 | 2024-04-08 | Marinaro Michael | Officer - EVP & President, Surgical OU | SELL | $83.14 | 854 | $71,002 | 27,925 | -3.0% |
| 2024-02-24 01:18 | 2024-02-21 | Salmon Sean | Officer - EVP & President Cardiovascular | OPT+S | $85.13 | 30,695 | $2,613,056 | 48,289 | 0.0% |
| 2023-12-20 19:41 | 2023-12-19 | Wall Brett A. | Officer - EVP & Pres Neuroscience | SELL | $82.17 | 4,997 | $410,603 | 28,910 | -14.7% |
| 2023-08-25 22:21 | 2023-08-23 | Smith Gregory L | Officer - EVP Global Ops & Supply Chain | SELL | $83.84 | 10,000 | $838,400 | 46,723 | -17.6% |
| 2023-08-17 00:16 | 2023-08-14 | Wall Brett A. | Officer - EVP & Pres Neuroscience | SELL | $83.38 | 1,000 | $83,380 | 33,573 | -2.9% |
| 2023-08-08 03:47 | 2023-08-04 | Marinaro Michael | Officer - EVP & President, Surgical OU | OPT+S | $84.11 | 1,352 | $113,717 | 28,930 | 0.0% |
| 2023-07-18 23:16 | 2023-07-14 | Wall Brett A. | Officer - EVP & Pres Neuroscience | SELL | $87.97 | 2,000 | $175,940 | 23,948 | -7.7% |
| 2023-07-12 22:48 | 2023-07-10 | TEN HOEDT ROB | Officer - EVP and Pres. Global Regions | OPT+S | $86.58 | 5,514 | $477,420 | 43,802 | 0.0% |
| 2022-12-16 15:28 | 2022-12-13 | Salmon Sean | Officer - EVP & President Cardiovascular | OPT+S | $80.50 | 16,631 | $1,338,736 | 36,088 | 0.0% |
| 2022-10-18 01:08 | 2022-10-14 | TEN HOEDT ROB | Officer - EVP and Pres. Global Regions | OPT+S | $81.54 | 2,404 | $196,015 | 43,483 | 0.0% |
| 2022-03-22 02:34 | 2022-03-18 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $110.00 | 682 | $75,020 | 34,946 | -1.9% |
| 2022-03-15 00:46 | 2022-03-11 | Surface Carol A | Officer - SVP, Chief HR Officer | SELL | $105.30 | 6,000 | $631,800 | 28,502 | -17.4% |
| 2021-12-28 02:31 | 2021-12-23 | WHITE ROBERT JOHN | Officer - EVP & Pres. Medical Surgical | SELL | $102.04 | 7,218 | $736,525 | 39,430 | -15.5% |
| 2021-12-18 00:57 | 2021-12-16 | ANDERSON RICHARD H | Director | BUY | $103.26 | 5,010 | $517,333 | 108,374 | +4.8% |
| 2021-12-08 02:23 | 2021-12-06 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $110.00 | 682 | $75,020 | 35,446 | -1.9% |
| 2021-10-02 01:13 | 2021-09-30 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | OPT+S | $126.58 | 49,147 | $6,221,027 | 48,763 | 0.0% |
| 2021-09-02 00:27 | 2021-08-31 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | OPT+S | $134.17 | 50,775 | $6,812,482 | 48,763 | 0.0% |
| 2021-08-27 02:28 | 2021-08-25 | Salmon Sean | Officer - EVP & Pres Diabetes/Cardiovasc | OPT+S | $134.08 | 28,419 | $3,810,493 | 33,329 | 0.0% |
| 2021-08-27 02:26 | 2021-08-25 | Martha Geoffrey | Director, Officer - CEO | OPT+S | $132.67 | 11,581 | $1,536,451 | 95,836 | 0.0% |
| 2021-08-05 01:18 | 2021-08-02 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | SELL | $131.52 | 4,000 | $526,080 | 48,194 | -7.7% |
| 2021-07-01 01:21 | 2021-06-28 | Martha Geoffrey | Director, Officer - CEO | OPT+S | $125.29 | 11,500 | $1,440,835 | 81,948 | 0.0% |
| 2021-06-23 00:58 | 2021-06-21 | Wall Brett A. | Officer - EVP & Pres Neuroscience | OPT+S | $123.50 | 115 | $14,203 | 21,602 | 0.0% |
| 2021-06-18 01:11 | 2021-06-15 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $124.47 | 605 | $75,304 | 86,223 | -0.7% |
| 2021-06-03 01:00 | 2021-06-01 | Wall Brett A. | Officer - EVP & Pres Neuroscience | OPT+S | $128.07 | 2,473 | $316,717 | 21,487 | 0.0% |
| 2021-06-02 00:55 | 2021-05-28 | Liddicoat John R | Officer - EVP & President of Americas | OPT+S | $126.65 | 34,656 | $4,389,182 | 42,551 | 0.0% |
| 2021-04-07 23:28 | 2021-04-05 | Martha Geoffrey | Director, Officer - CEO | OPT+S | $118.83 | 11,712 | $1,391,737 | 81,938 | 0.0% |
| 2021-03-17 00:19 | 2021-03-15 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $119.12 | 632 | $75,284 | 86,556 | -0.7% |
| 2021-03-04 01:23 | 2021-03-02 | TEN HOEDT ROB | Officer - EVP & President EMEA | OPT+S | $117.98 | 7,168 | $845,681 | 43,797 | 0.0% |
| 2020-12-31 00:42 | 2020-12-28 | Surface Carol A | Officer - SVP, Chief HR Officer | SELL | $114.90 | 15,000 | $1,723,500 | 34,150 | -30.5% |
| 2020-12-24 00:35 | 2020-12-22 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | SELL | $115.56 | 2,605 | $301,034 | 51,543 | -4.8% |
| 2020-12-22 01:06 | 2020-12-18 | WHITE ROBERT JOHN | Officer - EVP & Pres. Medical Surgical | SELL | $115.46 | 10,930 | $1,261,978 | 44,922 | -19.6% |
| 2020-12-17 01:34 | 2020-12-15 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $114.33 | 670 | $76,601 | 86,897 | -0.8% |
| 2020-11-11 01:18 | 2020-11-09 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | OPT+S | $113.13 | 20,715 | $2,343,488 | 54,148 | 0.0% |
| 2020-10-15 01:38 | 2020-10-09 | ISHRAK OMAR | Director, Officer - Executive Chairman | SELL | $108.40 | 763 | $82,709 | 561,032 | -0.1% |
| 2020-10-10 00:12 | 2020-10-08 | Lerman Bradley E | Officer - SVP General Counsel & Corp Sec | OPT+S | $110.00 | 20,714 | $2,278,540 | 54,325 | 0.0% |
| 2020-10-10 00:10 | 2020-10-08 | ANDERSON RICHARD H | Director | BUY | $108.52 | 4,607 | $499,952 | 101,673 | +4.7% |
| 2020-09-26 00:42 | 2020-09-23 | TEN HOEDT ROB | Officer - EVP & President EMEA | SELL | $104.34 | 9,584 | $999,995 | 43,476 | -18.1% |
| 2020-09-17 00:40 | 2020-09-15 | PARKHILL KAREN L | Officer - EVP & Chief Financial Officer | SELL | $107.78 | 702 | $75,662 | 87,366 | -0.8% |
| 2020-09-12 01:04 | 2020-09-09 | TEN HOEDT ROB | Officer - EVP & President EMEA | SELL | $105.05 | 9,563 | $1,004,593 | 53,060 | -15.3% |
| 2020-06-03 00:39 | 2020-05-29 | Surface Carol A | Officer - SVP, Chief HR Officer | SELL | $97.72 | 2,000 | $195,440 | 47,443 | -4.0% |
| 2020-02-24 16:56 | 2020-02-20 | ISHRAK OMAR | Director, Officer - Chairman & CEO | BUY | $113.68 | 8,771 | $997,087 | 605,190 | +1.5% |
| 2019-12-27 01:36 | 2019-12-24 | Kuntz Richard | Officer - SVP & Chief Medical & Science | OPT+S | $113.58 | 50,856 | $5,776,102 | 71,013 | 0.0% |
| 2019-12-10 01:36 | 2019-12-06 | ANDERSON RICHARD H | Director | BUY | $113.29 | 5,000 | $566,450 | 95,231 | +5.5% |
| 2019-12-04 00:25 | 2019-12-02 | WHITE ROBERT JOHN | Officer - EVP & President MITG | OPT+S | $110.62 | 52,166 | $5,770,827 | 52,068 | 0.0% |
How to Interpret $MDT Trades
Not every insider transaction in Medtronic plc is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MDT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for MDT
Insider activity data for Medtronic plc is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MDT, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.